High Cancer Burden Shifted From Urban to Rural Areas and Gap Widening
cancer - Two American Cancer Society studies highlight increase in cancer burden in rural areas
AI Summary: Recent analyses show the colorectal cancer burden has moved increasingly from urban centers to rural areas, widening disparities. Researchers attribute the shift to screening shortfalls, limited access to specialty care and socioeconomic barriers, and call for targeted screening, resource reallocation and tailored prevention efforts as rural populations face rising incidence and poorer outcomes.
- Clinical trials and treatment advances (6)
- Early-onset, prevention, and genetics (5)
- Rural burden and access disparities (8)
- All Other Stories
Clinical trials and treatment advances
Early-onset, prevention, and genetics
Rural burden and access disparities
All Other Stories
Nadia Care raises $12M to grow Medicaid maternal care
Ngai Yeung / endpoints - A maternal care startup offering virtual and in-person care just raised $12 million in new funding after dropping commercial insurers to focus on Medicaid, Endpoints News learned exclusively. Nadia Care, previously known as Cayaba Care ...
AI Summary: Nadia Care secured $12 million to expand its community‑centered maternal care model, increasing Medicaid‑focused doula and perinatal support services. The funding aims to scale access in underserved areas, bolster nonclinical supports that improve outcomes, and reduce maternal health disparities — because apparently traditional care alone wasn't cutting it.
A blood test may tailor breast cancer treatment for older women
medicalxpress - For women age 70 and over with a common form of breast cancer, determining "the right size" of treatment can be challenging, in part because clinicians have limited tools to guide individualized treatment decisions. In a study published today in Clinical …
AI Summary: An ultra‑sensitive circulating tumor DNA assay shows promise in tailoring treatment for older breast cancer patients by detecting molecular signals that could guide therapy decisions and avoid unnecessary interventions. The blood test aims to refine risk stratification and personalize care where standard approaches often lack nuance, potentially sparing frail patients from overtreatment.
- EBCC15: Less overtreatment through personalized radiotherapy and surveillance (4)
- Liquid biopsies and sensors advancing cancer detection beyond breast (4)
- Other: biology and global burden stories (3)
- Ultrasensitive ctDNA: tailoring breast cancer care for older patients (5)
- All Other Stories
EBCC15: Less overtreatment through personalized radiotherapy and surveillance
Liquid biopsies and sensors advancing cancer detection beyond breast
Other: biology and global burden stories
Ultrasensitive ctDNA: tailoring breast cancer care for older patients
All Other Stories
Vivek Subbiah: New Nature Study on Thymic Health and Response
oncodaily - Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on LinkedIn: “Wow published in NATURE journal ‘Thymic health and immunotherapy outcomes in patients […]
AI Summary: A new Nature study reveals that adult thymic health materially affects immune aging and responses to cancer treatment. Researchers show thymic integrity correlates with stronger immune surveillance and better therapy outcomes, reviving interest in thymus-targeted interventions. Experts describe the finding as a necessary reappraisal of an organ long written off by adult medicine — cue the applause.
- Aging immunity: why older immune systems fail us (5)
- Front lines: new targets and tactics in cancer immunotherapy (9)
- On the ground: adult thymus drives longevity and therapy success (5)
- All Other Stories
Aging immunity: why older immune systems fail us
Front lines: new targets and tactics in cancer immunotherapy
On the ground: adult thymus drives longevity and therapy success
All Other Stories
TerraPower Isotopes Invests $450M in Actinium-225 Production Facility
oncodaily - TerraPower Isotopes (TPI), the Bill Gates-founded nuclear science company, unveiled plans on March 17, 2026 to invest $450 million in a state-of-the-art actinium-225 (Ac-225) manufacturing facility in Philadelphia’s Bellwether District. The 250,000-square…
AI Summary: TerraPower announced a $450 million investment to construct a commercial Actinium‑225 production facility to supply alpha‑emitting radioisotopes for targeted cancer therapies. The plan tackles chronic supply shortages, strengthens domestic radiopharmaceutical capacity and positions the company at the center of growing demand for targeted‑alpha therapeutics — and yes, investors are watching.
This common vaccine cuts heart risk nearly in half in new study
sciencedaily - A shingles vaccine might double as a powerful heart protector. In people already at high risk, it cut major cardiac events by 46% and deaths by an impressive 66% within a year. Scientists think preventing shingles may also stop clot-related complications …
AI Summary: New research finds that receipt of a common shingles vaccine is associated with roughly a 50% reduction in serious cardiac events in the studied population. Investigators propose immune‑modulating mechanisms may underlie the protective effect; if confirmed, the vaccine could offer a tidy twofer—preventing shingles and cutting heart risk—proof that prevention sometimes moonlights as cardiology.
Updated: Lilly’s triple-G comparable with Mounjaro, first Phase 3 diabetes data suggest
Elizabeth Cairns / endpoints - Eli Lilly’s so-called triple-G reduced blood sugar levels in patients with type 2 diabetes by up to 1.9% in a late-stage trial — a similar margin as Mounjaro achieved in its pivotal diabetes study. The triple-G ...
AI Summary: Eli Lilly’s third‑generation GLP‑1 candidate reported Phase 3 data demonstrating significant weight loss and A1C reductions, with efficacy appearing comparable to existing therapies like Mounjaro. The results sharpen competition in the GLP‑1 market and raise questions about pricing, access and who gets first dibs on the next blockbuster injection.
- At clinics: GLP‑1 demand reshaping access, care and pricing (5)
- In labs: oral pills and novel GLP‑1 delivery approaches (4)
- On the ground: Lilly's triple‑G rivaling Mounjaro in trials (3)
- Other: clinical oddities, surgical implications and pipeline setbacks (5)
At clinics: GLP‑1 demand reshaping access, care and pricing
In labs: oral pills and novel GLP‑1 delivery approaches
On the ground: Lilly's triple‑G rivaling Mounjaro in trials
Other: clinical oddities, surgical implications and pipeline setbacks
A liquid biopsy blood test may improve children's survival of cancer in Africa
medicalxpress - In a study published in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of Health and Allied Sciences (MUHAS) in Dar es Salaam, Tanzania have shown that a minimally invasive liquid biopsy test can diagnose Burkitt l…
AI Summary: A blood‑based liquid biopsy for EBV‑positive Burkitt’s lymphoma shows promise for earlier, less invasive diagnosis in endemic regions, potentially improving pediatric survival where tissue biopsies are scarce. Early data indicate actionable sensitivity and feasibility for low‑resource settings, offering a scalable path to faster treatment.
What happens to your brain in nature? The neuroscience explained
medicalxpress - Have you ever felt calmer almost as soon as you step into the woods? Or maybe noticed your busy mind soften as you look out at the sea?
AI Summary: Researchers report that immersive time in natural settings produces detectable changes in brain networks tied to attention, emotion regulation and memory. The findings suggest brief nature exposure can recalibrate neural states and boost mental health — science’s polite way of telling you to go outside instead of doomscrolling.
Verily raises $300M, sheds Alphabet’s majority control
Shelby Livingston / endpoints - Verily has raised $300 million in new, outside funding that ends parent company Alphabet's controlling position in the healthcare innovation company, Endpoints News has learned exclusively. The funding round was led by Series X Capital ...
AI Summary: Verily secured a $300 million financing round that reduces Alphabet’s majority control, bringing new strategic investors on board including health system partners. The cash infusion aims to accelerate Verily’s healthcare technology and platform ambitions — because nothing says “healthcare disruption” like another well‑funded pivot.
Engineered tissue offers hope for children born with 'missing' esophagus
medicalxpress - Scientists from Great Ormond Street Hospital (GOSH) and University College London (UCL) have created the first lab‑grown esophagus—the food pipe—shown to safely replace a full section of the organ and restore normal function, including swallowing, in a gr…
AI Summary: Researchers report progress developing lab-grown esophageal tissue to treat children born with congenital absence or severe damage of the esophagus. Early preclinical and surgical work demonstrates that engineered tissue constructs can be implanted and integrated, offering a potential alternative to complex reconstructions — a promising step for tiny patients with very big problems.
Turquoise Health Snags $40M to Simplify Healthcare Contracts & Payments
Katie Adams / medcitynews - Turquoise Health raised $40 million in a Series C round to expand beyond price transparency into managing healthcare contracts. The startup’s platform aims to simplify payer–provider agreements, reduce administrative waste and enable patients to see guara…
AI Summary: Turquoise Health closed a $40 million funding round to accelerate its platform that standardizes healthcare contracts and payments, aiming to increase price transparency and streamline payer–provider interactions. The cash infusion will support product growth, sales expansion and the company's push to make messy contract data slightly less catastrophic for hospital finance teams.
Rob Winn Appointed Director of NCI-Designated Fox Chase Cancer Center
oncodaily - Fox Chase Cancer Center shared a post on LinkedIn: “Temple Health – Temple University Health System today announced the appointment of Dr. Rob Winn, MD, as the next Cancer Center […]
AI Summary: Rob Winn has been appointed director of the NCI‑designated Fox Chase Cancer Center, taking the reins of clinical, research and strategic operations. His role will focus on strengthening translational research, patient care integration and institutional partnerships to advance the center's mission — you know, the usual: cure more cancer, argue less in committee meetings.
Why Providence Wants to Sell Its Health Plan
Katie Adams / medcitynews - Providence announced its intent to sell its health plan, exiting the “payvider” model as rising costs and operational complexity weigh on smaller regional insurers. The move reflects a broader trend of health systems refocusing on core care delivery and e…
AI Summary: Providence Healthcare is actively weighing the sale of its health insurance arm as mounting fiscal pressures force leaders to consider dramatic options. The move would reshape the system’s payer-provider footprint, potentially easing balance‑sheet strain while unnerving patients, employers and regulators who’ll suddenly have a stake in the decision.
Lantern Secures $30M to Fuel Growth Across Employers and Health Plans
Marissa Plescia / medcitynews - Lantern’s $30 million raise was led by Morgan Health, a JPMorganChase business unit focused on employer-sponsored healthcare, as well as Echo Health Ventures, a strategic investment platform that invests on behalf of multiple Blues health plans.The post L…
AI Summary: Lantern secured a $30 million investment led by Morgan Health and Echo Health Ventures to scale its employer- and plan-facing digital health platform. The capital will accelerate product development, deepen payer-employer partnerships, and expand deployment of Lantern’s care navigation and benefits tools as it chases broader market traction — because nothing says progress like more tech for paperwork.
Sutter, Allina Health Combine to Form $26B Health System
Katie Adams / medcitynews - Sutter Health is acquiring Allina Health in a deal that would create a $26 billion nonprofit health system spanning California, Minnesota and Wisconsin. The deal reflects a broader wave of hospital consolidation as providers pursue scale to manage rising …
AI Summary: Sutter Health and Allina Health have agreed to combine in a transaction that would create a $26 billion nonprofit system spanning California and Minnesota, forming a 39‑hospital network. The deal aims to consolidate operations and expand market reach, subject to definitive agreements and regulatory approvals, promising scale-driven efficiencies — and inevitably, some rebranded parking lots.
- Close watch: finances, approvals and expected closing timeline (2)
- On the ground: Sutter and Allina agree to $26B merger (3)
- Other developments: regional hospital expansions and financing moves (2)
- Trend watch: consolidation reshaping hospital markets nationwide (2)
- All Other Stories
Close watch: finances, approvals and expected closing timeline
On the ground: Sutter and Allina agree to $26B merger
Other developments: regional hospital expansions and financing moves
Trend watch: consolidation reshaping hospital markets nationwide
All Other Stories
‘Lack of Substantial Evidence’ Leads to FDA Rejection of Aldeyra Dry Eye Disease Drug
Frank Vinluan / medcitynews - Aldeyra said the FDA did not ask for another clinical trial for reproxalap in dry eye disease, but the drug’s mixed record in clinical testing warrants exploration about the reasons for failure, which could identify the appropriate patients for the eye dr…
AI Summary: The FDA has rejected Aldeyra’s reproxalap application, citing a lack of substantial evidence—marking the company’s third setback. Regulators did not demand a fresh, large trial but flagged inconsistent results, prompting investor angst and a slide in the stock. The decision underscores the gap between hopeful early data and regulatory standards.
'Leaky' brain barrier revealed as driver of chronic brain damage in retired combat and collision sports athletes
medicalxpress - Research, led by teams at Trinity College Dublin and the FutureNeuro Research Ireland Center, has pinpointed the mechanism linking some sports injuries to poor brain health in retired athletes. The research, published in Science Translational Medicine, ha…
AI Summary: New research links repetitive head impacts in contact and combat sports to blood–brain barrier breakdown, which appears to drive chronic traumatic encephalopathy and progressive cognitive decline. The studies identify vascular leakage as a key mechanism and suggest that strategies to bolster the barrier could reduce long-term brain damage in athletes and veterans.
Britain rushes to contain deadly meningitis outbreak
medicalxpress - Over 10 people were hospitalized in the UK and students urged to take preventative antibiotics Tuesday as health officials rushed to treat a deadly meningitis outbreak linked to a nightclub.
AI Summary: Health officials in southern England have mounted an urgent response to a fast‑moving meningococcal outbreak tied to student nightlife in Kent, after multiple hospitalizations and at least two deaths. Authorities are offering antibiotics, assessing vaccine policy for teens, and urging vigilance as contact tracing and public health measures try to stop transmission before more young people fall ill.
- Human stories: parents and survivors recount meningitis's devastation (5)
- Live from Kent: explosive student meningitis outbreak and response (14)
- Other coverage: science, trials and unrelated tech pieces (9)
- Policy spotlight: why teens missed MenB vaccine, debate intensifies (6)
- All Other Stories
Human stories: parents and survivors recount meningitis's devastation
Live from Kent: explosive student meningitis outbreak and response
Other coverage: science, trials and unrelated tech pieces
Policy spotlight: why teens missed MenB vaccine, debate intensifies
All Other Stories
Bluesky Mentions: @justinhendrix.bsky.social
Federal court blocks RFK Jr.’s moves to upend US vaccine policy
Delilah Alvarado / healthcaredive - The ruling, related to a lawsuit from several major medical organizations, said that HHS ignored established protocols when altering the childhood immunization schedule and overhauling a key CDC panel.
AI Summary: A federal judge blocked actions by an HHS official seeking to alter longstanding childhood vaccine policies, ruling the department failed to follow established procedures. The decision reaffirms agency protocol for vaccine recommendations and curbs abrupt unilateral policy shifts, restoring a measure of regulatory due process.
- Courts curb HHS unilateral actions across vaccines and gender care (6)
- HHS leadership chaos and White House reining in RFK Jr. (3)
- States push back, setting their own vaccine policies (1)
- All Other Stories